Renaissance Technologies’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
299,937
+168,400
| +128% | +$957K | ﹤0.01% | 2215 |
|
|
2025
Q1 | $626K | Buy |
131,537
+42,300
| +47% | +$201K | ﹤0.01% | 2647 |
|
|
2024
Q4 | $497K | Sell |
89,237
-45,041
| -34% | -$251K | ﹤0.01% | 2846 |
|
|
2024
Q3 | $849K | Sell |
134,278
-369,015
| -73% | -$2.33M | ﹤0.01% | 2547 |
|
|
2024
Q2 | $2.13M | Buy |
503,293
+429,456
| +582% | +$1.82M | ﹤0.01% | 1846 |
|
|
2024
Q1 | $535K | Sell |
73,837
-108,556
| -60% | -$787K | ﹤0.01% | 2833 |
|
|
2023
Q4 | $914K | Buy |
182,393
+151,556
| +491% | +$759K | ﹤0.01% | 2465 |
|
|
2023
Q3 | $130K | Sell |
30,837
-2,700
| -8% | -$11.4K | ﹤0.01% | 3193 |
|
|
2023
Q2 | $135K | Sell |
33,537
-3,300
| -9% | -$13.3K | ﹤0.01% | 3397 |
|
|
2023
Q1 | $104K | Sell |
36,837
-25,800
| -41% | -$72.8K | ﹤0.01% | 3483 |
|
|
2022
Q4 | $193K | Sell |
62,637
-5,500
| -8% | -$16.9K | ﹤0.01% | 3434 |
|
|
2022
Q3 | $207K | Sell |
68,137
-27,790
| -29% | -$84.4K | ﹤0.01% | 3369 |
|
|
2022
Q2 | $499K | Buy |
95,927
+2,894
| +3% | +$15.1K | ﹤0.01% | 3165 |
|
|
2022
Q1 | $733K | Buy |
93,033
+5,928
| +7% | +$46.7K | ﹤0.01% | 2931 |
|
|
2021
Q4 | $734K | Buy |
87,105
+85,125
| +4,299% | +$717K | ﹤0.01% | 2879 |
|
|
2021
Q3 | $55K | Buy |
+1,980
| New | +$55K | ﹤0.01% | 3368 |
|
|
2021
Q2 | – | Sell |
-20,891
| Closed | -$982K | – | 3408 |
|
|
2021
Q1 | $982K | Sell |
20,891
-32,025
| -61% | -$1.51M | ﹤0.01% | 2617 |
|
|
2020
Q4 | $2.08M | Buy |
52,916
+45,706
| +634% | +$1.79M | ﹤0.01% | 2094 |
|
|
2020
Q3 | $184K | Sell |
7,210
-131
| -2% | -$3.34K | ﹤0.01% | 3127 |
|
|
2020
Q2 | $535K | Buy |
7,341
+4,332
| +144% | +$316K | ﹤0.01% | 2851 |
|
|
2020
Q1 | $158K | Buy |
+3,009
| New | +$158K | ﹤0.01% | 3142 |
|